!Series_title	"Whole transcriptome sequencing of major depressive disorder (MDD) patients and healthy controls"
!Series_geo_accession	"GSE190518"
!Series_status	"Public on Mar 21 2022"
!Series_submission_date	"Dec 09 2021"
!Series_last_update_date	"Apr 20 2022"
!Series_pubmed_id	"35431783"
!Series_summary	"We do this study to identify and validate the differentially expressed circRNAs in MDD patients and to evaluate their potential as diagnostic biomarkers and as novel therapeutic targets for MDD, to explore the potential clinical value and possible mechanism of circRNAs in MDD."
!Series_overall_design	"Whole transcriptome sequencing of 4 MDD patients and 4 healthy controls"
!Series_type	"Expression profiling by high throughput sequencing"
!Series_type	"Non-coding RNA profiling by high throughput sequencing"
!Series_contributor	"Yujie,,Cai"
!Series_contributor	"Dandan,,Zhang"
!Series_contributor	"Yao,,Ji"
!Series_sample_id	"GSM5725177 GSM5725178 GSM5725179 GSM5725180 GSM5725181 GSM5725182 GSM5725183 GSM5725184 "
!Series_contact_name	"Yujie,,Cai"
!Series_contact_email	"caiyujie@gdmu.edu.cn"
!Series_contact_phone	"18022643484"
!Series_contact_laboratory	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"
!Series_contact_institute	"Affiliated Hospital of Guangdong Medical University"
!Series_contact_address	"Renmindadaonan 57th"
!Series_contact_city	"Zhanjiang"
!Series_contact_state	"Guangdong"
!Series_contact_zip/postal_code	"524001"
!Series_contact_country	"China"
!Series_supplementary_file	"ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE190nnn/GSE190518/suppl/GSE190518_circRNA.count.txt.gz"
!Series_supplementary_file	"ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE190nnn/GSE190518/suppl/GSE190518_mRNA.count.fpkm.txt.gz"
!Series_platform_id	"GPL20301"
!Series_platform_taxid	"9606"
!Series_sample_taxid	"9606"
!Series_relation	"BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA787461"

!Sample_title	"C7"	"C8"	"C9"	"C10"	"D31"	"D32"	"D33"	"D35"
!Sample_geo_accession	"GSM5725177"	"GSM5725178"	"GSM5725179"	"GSM5725180"	"GSM5725181"	"GSM5725182"	"GSM5725183"	"GSM5725184"
!Sample_status	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"	"Public on Mar 21 2022"
!Sample_submission_date	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"	"Dec 09 2021"
!Sample_last_update_date	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"	"Mar 21 2022"
!Sample_type	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"
!Sample_channel_count	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"
!Sample_source_name_ch1	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"	"Cubital vein peripheral whole blood"
!Sample_organism_ch1	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"
!Sample_characteristics_ch1	"disease state: healthy controls"	"disease state: healthy controls"	"disease state: healthy controls"	"disease state: healthy controls"	"disease state: major depressive disorder patients"	"disease state: major depressive disorder patients"	"disease state: major depressive disorder patients"	"disease state: major depressive disorder patients"
!Sample_characteristics_ch1	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"	"tissue: Cubital vein peripheral whole blood"
!Sample_treatment_protocol_ch1	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."	"MDD patients were recruited through outpatients and inpatients in the Department of Psychology of the Affiliated Hospital of Guangdong Medical University. All MDD patients met the following inclusion criteria: (1)Met the MDD diagnostic criteria of Manual of Mental Disorders (5th Edition) (DSM­V); (2) The 24-item Hamilton Depression Scale (HAMD-24) score >= 8, Self-rating depression scale (SDS) score >= 53; (3) Age 14 to 59 years, and the age of MDD onset under 55 years; (4) Han people; (5) First episode depression patients without any medications or not taking any psychiatric medication for at least three months; (6) No history of infection, no obvious physical disorder; (7) No history of smoking or alcoholism; (8) No history of head trauma. And the following exclusion criteria were applied for the MDD patients: (1) With other mental disorder, e.g., substance abuse, schizophrenia, obsessive-compulsive disorder, etc.; (2) Pregnant or lactating female; (3) Long-term use of drugs or health care products. The healthy controls were recruited in the community and the inclusion criteria were as following: (1) The 24-item Hamilton Depression Scale (HAMD-24) score < 8, Self-rating depression scale (SDS) score < 53; (2) Age 18 to 59 years; (3) Han people; (4) Not taking any medication for at least three months; (5) No history of mental disorder and no family history of major mental disorder, no significant physical disorder; (6) No history of smoking or alcohol abuse. The following exclusion criteria were applied for the healthy controls:(1) Pregnant or lactating female; (2) Long-term use of drugs or health care products. All participants were jointly diagnosed by two or more psychiatrists."
!Sample_molecule_ch1	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"
!Sample_extract_protocol_ch1	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."	"Use EDTA anticoagulation tube to collect  blood, aliquot it into centrifuge tube and quick-freeze it in liquid nitrogen and store it at -80℃."
!Sample_extract_protocol_ch1	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."	"A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Firstly,ribosomal RNA was removed by Epicentre Ribo-zero™ rRNA Removal Kit (Epicentre, USA), and rRNA free residue was cleaned up by ethanol precipitation. Subsequently, sequencing libraries were generated using the rRNA-depleted RNA by NEBNext® Ultra™ Directional RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s recommendations."
!Sample_taxid_ch1	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"
!Sample_data_processing	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."	"Quality control: The quality of raw reads was first assessed using the FastQC. Raw data (raw reads) of fastq format were firstly processed through in-house perl scripts. In this step, clean data (clean reads) were obtained by removing reads containing adapter, reads containing ploy-N and low quality reads from raw data."
!Sample_data_processing	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."	"Genomic alignment and quantification: Reads were mapped to human genome assembly GRCh38 (ftp://ftp.ensembl.org/pub/release-89/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.toplevel.fa.gz) using HISAT2 with default parameters. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. GTF file:ftp://ftp.ebi.ac.uk/pub/databases/gencode/Gencode_human/release_29/gencode.v29.annotation.gtf.gz. The CIRCexplorer program (v2.3.8) was used to identify both the circularizing junction and the spliced sequence of circRNAs. All circRNA candidates with junction reads less than 2 were discarded. The remaining circRNA candidates were considered bonafide circRNAs."
!Sample_data_processing	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."	"DESeq2 (v2) was applied for the detection of differentially expressed mRNAs between tumor and non-tumor samples, the limma R package (3.40.6) was used for differentially expressed circRNAs."
!Sample_data_processing	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"	"Genome_build: GRCh38"
!Sample_data_processing	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"	"Supplementary_files_format_and_content: Tab-delimited text files include count and FPKM values for each sample"
!Sample_platform_id	"GPL20301"	"GPL20301"	"GPL20301"	"GPL20301"	"GPL20301"	"GPL20301"	"GPL20301"	"GPL20301"
!Sample_contact_name	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"	"Yujie,,Cai"
!Sample_contact_email	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"	"caiyujie@gdmu.edu.cn"
!Sample_contact_phone	"18022643484"	"18022643484"	"18022643484"	"18022643484"	"18022643484"	"18022643484"	"18022643484"	"18022643484"
!Sample_contact_laboratory	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"	"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases"
!Sample_contact_institute	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"	"Affiliated Hospital of Guangdong Medical University"
!Sample_contact_address	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"	"Renmindadaonan 57th"
!Sample_contact_city	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"	"Zhanjiang"
!Sample_contact_state	"Guangdong"	"Guangdong"	"Guangdong"	"Guangdong"	"Guangdong"	"Guangdong"	"Guangdong"	"Guangdong"
!Sample_contact_zip/postal_code	"524001"	"524001"	"524001"	"524001"	"524001"	"524001"	"524001"	"524001"
!Sample_contact_country	"China"	"China"	"China"	"China"	"China"	"China"	"China"	"China"
!Sample_data_row_count	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"
!Sample_instrument_model	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"	"Illumina HiSeq 4000"
!Sample_library_selection	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"
!Sample_library_source	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"
!Sample_library_strategy	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"
!Sample_relation	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805244"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805243"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805242"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805241"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805240"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805239"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805238"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN23805237"
!Sample_relation	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362829"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362830"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362831"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362832"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362833"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362834"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362835"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX13362836"
!Sample_supplementary_file_1	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"
!series_matrix_table_begin
"ID_REF"	"GSM5725177"	"GSM5725178"	"GSM5725179"	"GSM5725180"	"GSM5725181"	"GSM5725182"	"GSM5725183"	"GSM5725184"
!series_matrix_table_end
